The first 30 years of p53: growing ever more complex

被引:1466
作者
Levine, Arnold J. [1 ]
Oren, Moshe [2 ]
机构
[1] Inst Adv Study, Sch Nat Sci, Princeton, NJ 08540 USA
[2] Weizmann Inst Sci, IL-76100 Rehovot, Israel
基金
美国国家卫生研究院;
关键词
WILD-TYPE P53; CELLULAR TUMOR-ANTIGEN; SINGLE NUCLEOTIDE POLYMORPHISM; AUTOREGULATORY FEEDBACK LOOP; AMINO-ACID-SEQUENCE; SUPPRESSOR P53; MUTANT P53; TRANSCRIPTIONAL ACTIVATION; SV40-TRANSFORMED CELLS; GENE-EXPRESSION;
D O I
10.1038/nrc2723
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Thirty years ago p53 was discovered as a cellular partner of simian virus 40 large T-antigen, the oncoprotein of this tumour virus. The first decade of p53 research saw the cloning of p53 DNA and the realization that p53 is not an oncogene but a tumour suppressor that is very frequently mutated in human cancer. In the second decade of research, the function of p53 was uncovered: it is a transcription factor induced by stress, which can promote cell cycle arrest, apoptosis and senescence. In the third decade after its discovery new functions of this protein were revealed, including the regulation of metabolic pathways and cytokines that are required for embryo implantation. The fourth decade of research may see new p53-based drugs to treat cancer. What is next is anybody's guess.
引用
收藏
页码:749 / 758
页数:10
相关论文
共 166 条
[41]   PRESENCE OF A POTENT TRANSCRIPTION ACTIVATING SEQUENCE IN THE P53 PROTEIN [J].
FIELDS, S ;
JANG, SK .
SCIENCE, 1990, 249 (4972) :1046-1049
[42]   p63: The phantom of the tumor suppressor [J].
Finlan, Lee E. ;
Hupp, Ted R. .
CELL CYCLE, 2007, 6 (09) :1062-1071
[43]   ACTIVATING MUTATIONS FOR TRANSFORMATION BY P53 PRODUCE A GENE-PRODUCT THAT FORMS AN HSC70-P53 COMPLEX WITH AN ALTERED HALF-LIFE [J].
FINLAY, CA ;
HINDS, PW ;
TAN, TH ;
ELIYAHU, D ;
OREN, M ;
LEVINE, AJ .
MOLECULAR AND CELLULAR BIOLOGY, 1988, 8 (02) :531-539
[44]   THE P53 PROTO-ONCOGENE CAN ACT AS A SUPPRESSOR OF TRANSFORMATION [J].
FINLAY, CA ;
HINDS, PW ;
LEVINE, AJ .
CELL, 1989, 57 (07) :1083-1093
[45]   A TRANSCRIPTIONALLY ACTIVE DNA-BINDING SITE FOR HUMAN P53 PROTEIN COMPLEXES [J].
FUNK, WD ;
PAK, DT ;
KARAS, RH ;
WRIGHT, WE ;
SHAY, JW .
MOLECULAR AND CELLULAR BIOLOGY, 1992, 12 (06) :2866-2871
[46]   WILD-TYPE P53 CAN DOWN-MODULATE THE ACTIVITY OF VARIOUS PROMOTERS [J].
GINSBERG, D ;
MECHTA, F ;
YANIV, M ;
OREN, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (22) :9979-9983
[47]   Cytoplasmic functions of the tumour suppressor p53 [J].
Green, Douglas R. ;
Kroemer, Guido .
NATURE, 2009, 458 (7242) :1127-1130
[48]   Ablation of Key Oncogenic Pathways by RITA-Reactivated p53 Is Required for Efficient Apoptosis [J].
Grinkevich, Vera V. ;
Nikulenkov, Fedor ;
Shi, Yao ;
Enge, Martin ;
Bao, Wenjie ;
Maljukova, Alena ;
Gluch, Angela ;
Kel, Alexander ;
Sangfelt, Olle ;
Selivanova, Galina .
CANCER CELL, 2009, 15 (05) :441-453
[49]  
HALEVY O, 1991, ONCOGENE, V6, P1593
[50]   The Estrogen Receptor α Pathway Induces Oncogenic Wip1 Phosphatase Gene Expression [J].
Han, Hye-Sook ;
Yu, Eunsil ;
Song, Ji-Young ;
Park, Ji-Young ;
Jang, Se Jin ;
Choi, Jene .
MOLECULAR CANCER RESEARCH, 2009, 7 (05) :713-723